Large-scale evidence that the cardiotoxicity of smoking is not significantly modified by the apolipoprotein E ε2/ε3/ε4 genotype
- 1 February 2003
- journal article
- Published by Elsevier in The Lancet
- Vol. 361 (9355) , 396-398
- https://doi.org/10.1016/s0140-6736(03)12386-0
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective studyThe Lancet, 2001
- Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controlsThe Lancet, 2000
- Utility of the predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men aged 65 to 84 years is dependent on context defined by Apo E genotype and area of residenceClinical Genetics, 1999
- Apolipoprotein E Alleles and Risk of Coronary DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Cigarette smoking, tar yields, and non-fatal myocardial infarction: 14000 cases and 32000 controls in the United KingdomBMJ, 1995